These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16816403)

  • 21. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.
    Moore SF; Hunter RW; Hers I
    J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.
    Park IH; Bachmann R; Shirazi H; Chen J
    J Biol Chem; 2002 Aug; 277(35):31423-9. PubMed ID: 12087098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y; Fanburg BL
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).
    Rolfe M; McLeod LE; Pratt PF; Proud CG
    Biochem J; 2005 Jun; 388(Pt 3):973-84. PubMed ID: 15757502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.
    Castro AF; Rebhun JF; Clark GJ; Quilliam LA
    J Biol Chem; 2003 Aug; 278(35):32493-6. PubMed ID: 12842888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.
    Goncharova EA; Goncharov DA; Chisolm A; Spaits MS; Lim PN; Cesarone G; Khavin I; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
    Mol Pharmacol; 2008 Mar; 73(3):778-88. PubMed ID: 18094073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.
    Tee AR; Anjum R; Blenis J
    J Biol Chem; 2003 Sep; 278(39):37288-96. PubMed ID: 12867426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A potential role for extracellular signal-regulated kinases in prostaglandin F2alpha-induced protein synthesis in smooth muscle cells.
    Rao GN; Madamanchi NR; Lele M; Gadiparthi L; Gingras AC; Eling TE; Sonenberg N
    J Biol Chem; 1999 Apr; 274(18):12925-32. PubMed ID: 10212283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
    Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
    J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
    Thomson DM; Fick CA; Gordon SE
    J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.
    Altman JK; Yoon P; Katsoulidis E; Kroczynska B; Sassano A; Redig AJ; Glaser H; Jordan A; Tallman MS; Hay N; Platanias LC
    J Biol Chem; 2008 Jan; 283(4):1992-2001. PubMed ID: 18048359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mammalian target of rapamycin-p70 ribosomal S6 kinase but not phosphatidylinositol 3-kinase-Akt signaling is responsible for fibroblast growth factor-9-induced cell proliferation.
    Wing LY; Chen HM; Chuang PC; Wu MH; Tsai SJ
    J Biol Chem; 2005 May; 280(20):19937-47. PubMed ID: 15760907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of Normal Cerebral Oxygen Consumption with Rapamycin Treatment in a Rat Model of Autism-Tuberous Sclerosis.
    Chi OZ; Wu CC; Liu X; Rah KH; Jacinto E; Weiss HR
    Neuromolecular Med; 2015 Sep; 17(3):305-13. PubMed ID: 26048361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells.
    Moschella PC; Rao VU; McDermott PJ; Kuppuswamy D
    J Mol Cell Cardiol; 2007 Dec; 43(6):754-66. PubMed ID: 17976640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF.
    Hannan KM; Brandenburger Y; Jenkins A; Sharkey K; Cavanaugh A; Rothblum L; Moss T; Poortinga G; McArthur GA; Pearson RB; Hannan RD
    Mol Cell Biol; 2003 Dec; 23(23):8862-77. PubMed ID: 14612424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
    Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
    J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
    Zhang H; Cicchetti G; Onda H; Koon HB; Asrican K; Bajraszewski N; Vazquez F; Carpenter CL; Kwiatkowski DJ
    J Clin Invest; 2003 Oct; 112(8):1223-33. PubMed ID: 14561707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
    Byfield MP; Murray JT; Backer JM
    J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.